The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The biopharma job market remains challenging, based on BioSpace data. In August, job postings live on the website dropped 32% ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the ...

Novo Nordisk › Finding undervalued stocks isn't easy these days. The average stock price for companies in the benchmark S&P ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

Wall Street inched to more records on Wednesday following a surprisingly encouraging report on inflation and a stunning forecast for growth from Oracle because of the artificial intelligence boom.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of ...

Sandwich maker Potbelly is being acquired by the gas station and convenience store chain RaceTrac for $566 million. Potbelly, ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.